Surgical Navigation System Market is expected to See Incredible Growth By 2030

The surgical navigation system market is anticipated to reach US$ 1,700 million by 2030, growing at a compound yearly growth rate of 6.2%.

When compared to surgeries without Surgical Navigation Systems, Surgical Navigation Systems is a dependable technology that has been designed to make surgeries safer and less invasive.

Navigation during surgery is an amazing technology that is now being applied in medical devices. Surgical Navigation Systems have facilitated more sophisticated procedures by speeding up technical procedures.

Surgical Navigation Systems target the anatomy to be operated on and guide implant placement to the specific anatomy of the human body in a safe manner. During surgeries, Surgical Navigation Systems function as information hubs.

In a virtual environment, a surgical navigation system is essential for correct anatomy visualisation and surgery planning. Surgical Navigation Systems aid in the reduction of surgical risks.

Surgical Navigation System Market: Overview

Surgical Navigation System is sometimes known as computer-aided surgery or computer-assisted intervention. Anatomical imaging is required by the navigation system, which leads to image analysis.

Based on the image provided, the navigation system aids in diagnosis and operation simulation. The neurosurgery segment dominates the global surgical navigation system market due to the intricacy of the procedures.

Orthopaedic navigation systems topped the global surgical navigation system market, closely followed by ENT navigation systems.

Surgical Navigation System Market: Key Players

Some of the key players in the global Surgical Navigation System are GE Healthcare Ltd., Medtronic Inc., Siemens Healthcare Corporation, Stryker Corporation, B.Braun Melsungen AG, Bausch & Lomb Incorporated, CAScination AG and Brainlab AG.

Browse More Details@ https://www.futuremarketinsights.com/reports/surgical-navigation-system-market

Key Segments

By Technology:

  • Electromagnetic Navigation Systems
  • Hybrid Navigation Systems
  • Optical Navigation Systems
  • Fluoroscopy-based Navigation Systems
  • CT-based Navigation System
  • Others

By Application:

  • Neurosurgery
  • Orthopedic Surgery
  • ENT surgery
  • Cardiac surgery
  • Others

By End Use:

  • Hospitals and Physician Practices
  • Ambulatory Surgery

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more